RSS

Kadclya,

NHS England has struck a deal with Roche and endorsed by the National Institute for Health and Care Excellence (NICE) to make the breast cancer drug Kadcyla available for routine use on the NHS. more

News

Jamie Mallinson, GlobalData’s analyst covering oncology and hematology, describes the NICE rejection as "no big surprise". more